A drug used to treat Parkinson's disease could also help people with phobias or post-traumatic stress disorder (PTSD), scientists report. They are currently exploring the effects of psychotherapy to ...
A drug already used safely to treat Parkinson's disease, restless leg syndrome and other movement disorders also could delay or prevent the most common cause of blindness affecting more than 9 million ...
Idiopathic Parkinson’s disease (IPD) is a central nervous system disorder affecting the basal ganglia that is caused by death of dopamine-producing cells in the substantia nigra. Although IPD is ...
In the vast majority of cases of Parkinson’s disease, or “shaking palsy,” physicians cannot be sure what originally caused the nerve damage that results in the patient’s tremor, muscle rigidity, ...
Researchers have discovered one of the first concrete examples of how the microbiome can interfere with a drug's intended path through the body. Focusing on levodopa (L-dopa), the primary treatment ...
The U.S. Food and Drug Administration has given approval for the drug Stalevo-a cocktail of levodopa (L-dopa), carbidopa, and entacapone-to be marketed in the United States for the treatment of ...
In today's Nature journals online, two articles provide new insights and new hope for the treatment of Parkinson's disease. In Nature Medicine, a collaboration led by Peter Heywood at Frenchay ...
A team of researchers has reported progress in testing a new approach involving the dopamine system that they hope may help reduce symptoms of post-traumatic stress disorder (PTSD). Led by 2014 BBRF ...
A team of researchers has reported progress in testing a new approach involving the dopamine system that they hope may help reduce symptoms of post-traumatic stress disorder (PTSD). Led by 2014 BBRF ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results